In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Argan, Inc.'s current price exceeds its PERT-weighted fair value by 5.5%, suggesting overvaluation with high confidence. Monte Carlo analysis shows significant downside risk, as all scenarios fall below the current price, highlighting considerable volatility and weak growth prospects. Strong profitability and leverage contrast sharply with minimal growth, indicating valuation risk.